BILL ANALYSIS �
AB 1967
Page 1
Date of Hearing: April 30, 2014
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Mike Gatto, Chair
AB 1967 (Pan) - As Amended: April 10, 2014
Policy Committee: HealthVote:19-0
Urgency: No State Mandated Local Program:
No Reimbursable: No
SUMMARY
This bill requires the Department of Health Care Services
(DHCS), if it commences or concludes an investigation of a Drug
Medi-Cal provider, to notify counties that contract with the
provider.
FISCAL EFFECT
Negligible state fiscal effect. DHCS has already committed to
improved communication with counties for purposes of program
integrity in the Drug Medi-Cal program.
COMMENTS
1)Purpose . According to the author, this bill is intended to
improve oversight and prevent fraud in the Drug Medi-Cal
program by requiring the state to share information with
counties related to providers under investigation. In
September 2013 the Assembly Health Committee and Assembly
Accountability and Administrative Review Committee held a
joint oversight hearing to examine fraud in the Drug Medi-Cal
program. One issue highlighted at the hearing was the lack of
information sharing between the state and county entities that
are responsible for monitoring and auditing clinics. In
particular, counties expressed a concern that individuals who
were being investigated in one county could simply move
operations to a new county in order to avoid further
investigation.
2)Background . Drug Medi-Cal services are reimbursed on a
fee-for-service basis at maximum rates set by the state.
Prior to this year, services included outpatient drug-free
AB 1967
Page 2
services, which consist mostly of group counseling and some
limited individual counseling for people in crisis, and
narcotic treatment programs, which provide methadone
replacement therapy. There were about 800 active Drug Medi-Cal
providers in the state providing these services.
Drug Medi-Cal is also expanding services. As of January 1 of
this year, intensive outpatient services, residential
services, and inpatient detoxification are available to the
general population. After recent allegations in the media of
systemic fraud in the Drug Medi-Cal system, DHCS conducted a
special review of Drug Medi-Cal, suspending numerous providers
and referring some to the Department of Justice. DHCS
indicates additional Drug Medi-Cal program integrity efforts
are ongoing.
3)Related Legislation .
a) AB 1644 (Medina) requires Drug Medi-Cal providers to be
designated as a 'high' categorical risk and be subject to
criminal background checks as a condition of Drug Medi-Cal
certification. AB 1644 is being heard today in this
committee.
b) SB 1339 (Cannella) requires a county or DHCS, before
contracting with a Drug Medi-Cal provider, to obtain
criminal background checks for the owner and key staff. SB
1339 is pending in the Senate.
c) SB 1045 (Beall) decreases, from four to two, the minimum
number of participants in a group counseling session
provided by certain Drug Medi-Cal providers and eliminates
the maximum of 10 participants. SB 1045 is pending in the
Senate.
Analysis Prepared by : Lisa Murawski / APPR. / (916) 319-2081